Drug
Cabergoline 0.5 MG
Cabergoline 0.5 MG is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
17%
Ph not_applicable
2
33%
Ph phase_2
3
50%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(3)
Completed(3)
Detailed Status
Completed3
Recruiting2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 23 (50.0%)
Phase 41 (16.7%)
N/A2 (33.3%)
Trials by Status
recruiting233%
completed350%
enrolling_by_invitation117%
Recent Activity
2 active trials
Showing 5 of 6
completedphase_2
Cabergoline for the Treatment of Chronic Pain Due to Endometriosis
NCT03928288
recruitingnot_applicable
Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS
NCT07255911
recruitingphase_2
Cabergoline for Episodic Migraine
NCT07072910
enrolling_by_invitationphase_4
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
NCT07034859
completednot_applicable
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611
Clinical Trials (6)
Showing 6 of 6 trials
NCT03928288Phase 2
Cabergoline for the Treatment of Chronic Pain Due to Endometriosis
NCT07255911Not Applicable
Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS
NCT07072910Phase 2
Cabergoline for Episodic Migraine
NCT07034859Phase 4
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
NCT05525611Not Applicable
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05981742Phase 2
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6